C.M. Bidwell & Associates »

Syndax Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.5k 308 21.01
2025-09-30 $4.7k 308 15.39

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Vanguard Total Stock Market ETF (VTI)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares Russell 2000 Index (IWM)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Schwab Strategic Tr sht tm us tres (SCHO)
iShares S&P 500 Index (IVV)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
Schwab Strategic Tr 0 (SCHP)
Dimensional Etf Trust (DFAC)
Schwab U S Broad Market ETF (SCHB)

View all positions for C.M. Bidwell & Associates

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Vanguard Group
Goldman Sachs Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Hood River Capital Management
Soleus Capital Management
Geode Capital Management
Ensign Peak Advisors
Nuveen

View all funds holding Syndax Pharmaceuticals